90 likes | 223 Views
Healthcare infrastructure – The section provides data on the current health and hygiene status of the citizens based parameters such as: sanitation and safe drinking water access, HIV/AIDS prevalence, contraceptive usage, maternal and infant mortality, hospital bed and physician density etc.
E N D
Healthcare Market Access: Morocco • Morocco has inadequate numbers of physicians (0.5 per 1,000 people) and hospital beds (1.0 per 1,000 people) and poor access to water (82 percent of the population) and sanitation (75 percent of the population). The health care system includes 122 hospitals, 2,400 health centers, and 4 university clinics, but they are poorly maintained and lack adequate capacity to meet the demand for medical care. Only 24,000 beds are available for 6 million patients seeking care each year, including 3 million emergency cases. The health budget corresponds to 1.1 percent of gross domestic product and 5.5 ercent of the central government budget For More Information Visit : www.aarkstore.com For More Information Visit : www.aarkstore.com
Summary • Country Landscape – The section details about the geographical details of Morocco. It also details the prevalent economic conditions of Morocco in terms of GDP per capita, GDP sources, demographic profile of the country, and political structure and environment. • Healthcare infrastructure – The section provides data on the current health and hygiene status of the citizens based parameters such as: sanitation and safe drinking water access, HIV/AIDS prevalence, contraceptive usage, maternal and infant mortality, hospital bed and physician density etc. The sections also give detailed account of general healthcare structure of the country in terms of primary, secondary and tertiary care, and also a general note on the country’s health expenditure. • Pharmaceutical Market Access: The sections gives detailed account of various types of health insurance currently operating in Morocco, their coverage in terms of health risks and benefits and also in terms of population coverage. The section gives detailed account of health insurance for public sector and private sector employees. The section also compares the efficiencies of various African medical regulatory agencies and their approval approach for a MNC pharmaceutical company. More specifically, the section deals with the regulatory agency and the new drug and reimbursement approval in Morocco. For More Information Visit : www.aarkstore.com
Why should you buy this report: As every country’s market access landscape is unique and evolving, it makes a prudent decision to have a country specific market access strategy. Moreover, the success of any pharmaceutical company hinges on successfully navigating challenges posed by the various stakeholders and regulatory bodies for effective product commercialization. This report will serve as a handy tool for pharmaceutical and other related healthcare stakeholders to:• Understand the macro and micro parameters that will play a pivotal role in making business decisions• Identify, target and collaborate with the relevant stakeholders that hold key to effective product commercialization• Conceptualize and formulate plausible market access strategies based on the insights generated • Identify and foresee the major trends and policies likely to impact the regulatory, pricing and reimbursement landscape of the country• Capitalize on the opportunities presented by the country’s pharmaceutical market and mitigate the challenges posed by the competitors and stakeholders/regulatory bodies• Generate market specific insights that are actionable and commercially viable • Leverage market access insights by incorporating physicians and payer priorities so as to develop effective sales and marketing strategies resulting in increased brand and company revenue• Correctly ascertain the appropriate market access levers and barriers that will drive or hamper the brand performance• Prioritize and assign optimal resources required for implementation of various market access activities For More Information Visit : www.aarkstore.com
Table of Content EXECUTIVE SUMMARY 6 2 COUNTRY LANDSCAPE 8 2.1 Geography 8 2.2 Economic environment 9 HEALTHCARE INFRASTRUCTURE 15 3.1.1 Healthcare system 17 MARKET ACCESS 21 4.1 Health insurance system 21 4.1.1 AMO: Mandatory health insurance (Assurance Maladie Obligatoire) 22 4.1.2 RAMED: Medical assistance scheme (Régime d’Assistance Médicale) 25 5 CONCLUSION 34 6 APPENDIX 35 6.1 Glossary 35 6.2 Coverage rates for long-term and costly conditions 37 6.3 Essential drug list of Morocco 41 6.4 Reimbursement of anti-cancer drugs (in MAD) 73 6.5 Bibliography 88 6.6 Methodology 89 6.6.1 Secondary research 89 6.6.2 Data validation 89 6.7 Disclaimer 89 6.8 Contact us 90 For More Information Visit : www.aarkstore.com
List of Tables Table 1: GDP Real growth rate of Morocco 8Table 2: GDP composition (2012 estimates) by sector of origin 8Table 3: Demographic breakdown of Morocco based on 2014 estimates 11Table 4: Major urban cities and their population based on 2011 estimates 11Table 5: Educational parameters 12Table 6: Access to safe drinking water and sanitation 14Table 7: Healthcare indicators of Morocco 16Table 8: Breakdown of healthcare delivery in public and private sectors 17Table 9: Breakdown of income and major expenditure of CNSS and CNOPS for 2012 24Table 10: Breakdown of income and major expenditure of RAMED for 2012 25Table 11: Coverage rates for long-term and costly conditions 36Table 12: Coverage rate of lasting and costly disorders 39Table 13: Essential drug list of Morocco 40Table 14: Reimbursements of anti-cancer drugs 72 For More Information Visit : www.aarkstore.com
List of Figures Figure 1: Changing trends of demographics of Morocco 10Figure 2: Breakdown share of hospital beds (A) in public and private hospitals 18Figure 3: Health care professionals (B) in public and private hospitals 18Figure 4: Financing of total health expenditure in Morocco 19Figure 5: Intended coverage of population by insurance scheme 20Figure 6: Share of AMO coverage by insurance provider 21Figure 7: CNSS pay-outs for short-term, long-term, and family care (A) 23Figure 8: CNSS beneficiaries receiving short-term, long-term, and family care (B) 23Figure 9: Drug approval and reimbursement process in Morocco 32 • Browse full report Or Sample Request @ • http://www.aarkstore.com/pharmaceuticals-healthcare/117429/healthcare-market-access-morocco For More Information Visit : www.aarkstore.com
Related Reports • Global Raman Spectroscopy Industry 2015 Market Research Report • Global Contraceptives Industry Report 2015 • Prescription Drugs Industry Forecasts - China Focus • Cardiovascular Devices Industry Forecasts - China Focus • Emerging Pharmaceuticals Industry Forecasts - China Focus For More Information Visit : www.aarkstore.com
Follow Us https://www.facebook.com/aarkstoredotcom https://twitter.com/aarkstore https://plus.google.com/+Aarkstoredotcom/posts https://www.linkedin.com/company/aarkstore-enterprise For More Information Visit : www.aarkstore.com
Office Address Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Mail us at contact@aarkstore.com 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 For More Information Visit : www.aarkstore.com